Deutsche Bank Ag\ Avadel Pharmaceuticals PLC Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.55 - $17.22 $1.57 Million - $2.15 Million	125,000 Added 28.41%	565,000 $9.54 Million
Q3 2023 Nov 09, 2023	BUY	$10.3 - $15.99 $2.21 Million - $3.44 Million	215,000 Added 95.56%	440,000 $4.53 Million
Q2 2023 Aug 14, 2023	BUY	$8.48 - $16.48 $1.91 Million - $3.71 Million	225,000 New	225,000 $3.71 Million
Q3 2022 Nov 14, 2022	SELL	$2.57 - $7.31 $147,821 - $420,456	-57,518 Reduced 46.01%	67,482 $338,000
Q2 2022 Aug 11, 2022	SELL	$1.07 - $6.95 $233,695 - $1.52 Million	-218,407 Reduced 63.6%	125,000 $305,000
Q3 2021 Nov 04, 2021	SELL	$6.49 - $9.91 $894,237 - $1.37 Million	-137,787 Reduced 28.63%	343,407 $3.37 Million
Q2 2021 Aug 11, 2021	BUY	$6.73 - $9.05 $360,176 - $484,337	53,518 Added 12.51%	481,194 $3.24 Million
Q4 2020 Feb 16, 2021	SELL	$5.03 - $7.95 $87,426 - $138,178	-17,381 Reduced 3.91%	427,676 $2.86 Million
Q3 2020 Nov 12, 2020	BUY	$5.02 - $8.98 $87,252 - $156,081	17,381 Added 4.06%	445,057 $2.24 Million
Q2 2020 Aug 13, 2020	SELL	$7.25 - $11.75 $1.16 Million - $1.89 Million	-160,631 Reduced 27.3%	427,676 $3.46 Million
Q3 2019 Nov 14, 2019	SELL	$1.92 - $4.47 $2,628 - $6,119	-1,369 Reduced 0.23%	588,307 $2.45 Million
Q2 2019 Aug 14, 2019	SELL	$1.09 - $3.19 $12,016 - $35,166	-11,024 Reduced 1.84%	589,676 $1.7 Million
Q1 2019 May 15, 2019	BUY	$1.44 - $3.29 $830,584 - $1.9 Million	576,795 Added 2412.86%	600,700 $864,000
Q4 2018 Feb 14, 2019	SELL	$1.74 - $4.66 $1.31 Million - $3.51 Million	-753,184 Reduced 96.92%	23,905 $61,000
Q3 2018 Dec 21, 2021	BUY	$4.08 - $7.14 $3.02 Million - $5.29 Million	740,917 Added 2048.32%	777,089 $3.41 Million
Q3 2018 Nov 14, 2018	SELL	$4.08 - $7.14 $4.56 Million - $7.99 Million	-1,118,590 Reduced 96.87%	36,172 $158,000
Q2 2018 Apr 21, 2020	BUY	$5.89 - $7.78 $3.08 Million - $4.07 Million	522,631 Added 82.68%	1,154,762 $7.08 Million
Q2 2018 Aug 14, 2018	SELL	$5.89 - $7.78 $3.59 Million - $4.74 Million	-609,301 Reduced 49.08%	632,131 $3.87 Million
Q1 2018 Oct 18, 2019	BUY	$6.76 - $11.7 $2.02 Million - $3.5 Million	299,013 Added 31.73%	1,241,432 $9.05 Million
Q1 2018 May 15, 2018	SELL	$6.76 - $11.7 $1.09 Million - $1.88 Million	-160,763 Reduced 14.57%	942,419 $6.87 Million
Q4 2017 Feb 14, 2018	SELL	$8.03 - $11.25 $73,554 - $103,050	-9,160 Reduced 0.82%	1,103,182 $9.05 Million
Q3 2017 Nov 14, 2017	BUY	$8.35 - $10.5 $9.29 Million - $11.7 Million	1,112,342	1,112,342 $11.7 Million

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $662M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account